scholarly journals Cervical Cancer Prevention and Cancer Control in Latin America—Letter

2015 ◽  
Vol 21 (24) ◽  
pp. 5644-5645 ◽  
Author(s):  
Tatiana Vidaurre
2021 ◽  
pp. 81-100
Author(s):  
Amira Burhan

Background: Although cervical cancer is largely preventable, it continues to be an important cause of morbidity and mortality in Sudan, due to the lack of national control programs. This study aimed to evaluate the availability of cervical cancer prevention services and assess the facility readiness in Khartoum state, as a base for future plans. Methods: This study was an observational, mixed-method, health service research. Purposive sampling method was used to select focal persons to explore the current situation and the available services qualitatively. Observation through standardized checklists of screening and colposcopy centers was conducted, and service providers were interviewed. Thematic analysis and descriptive statistics were used to analyze data. Results: Based on the qualitative interviews, Khartoum Oncology Hospital is the only specialized center providing chemotherapy and radiotherapy services for the state. Although six screening and nine diagnostic centers were surveyed, services were not available in most localities. Reasonable but unutilized resources in the secondary level exist at the time of the study, primary-level efforts to control cervical cancer are uncoordinated and ineffective, with no linked efforts at the community level. Since initiatives to reduce cervical cancer mortality need to adopt a holistic approach to the disease continuum, a comprehensive model was suggested and explained, the gaps and challenges were discussed. Conclusion: Cervical cancer prevention still remains a highly unaddressed need in Sudan. Sustainable financing of robust programs is necessary to achieve elimination. Contextually relevant devices must be selected to improve resource allocation. These results might be useful for the establishment of cervical cancer control in Sudan. Keywords: cervical cancer, screening, health system, developing countries, Sudan


Vaccine ◽  
2008 ◽  
Vol 26 ◽  
pp. L96-L107 ◽  
Author(s):  
Nubia Muñoz ◽  
Eduardo L. Franco ◽  
Rolando Herrero ◽  
Jon Kim Andrus ◽  
Ciro de Quadros ◽  
...  

Vaccine ◽  
2008 ◽  
Vol 26 ◽  
pp. L59-L72 ◽  
Author(s):  
Sue J. Goldie ◽  
Mireia Diaz ◽  
Dagna Constenla ◽  
Nelson Alvis ◽  
Jon Kim Andrus ◽  
...  

The Lancet ◽  
2019 ◽  
Vol 393 (10175) ◽  
pp. 969-970 ◽  
Author(s):  
Fanghui Zhao ◽  
Youlin Qiao

2011 ◽  
Vol 2011 ◽  
pp. 1-24 ◽  
Author(s):  
Hextan Y. S. Ngan ◽  
Suzanne M. Garland ◽  
Neerja Bhatla ◽  
Sonia R. Pagliusi ◽  
Karen K. L. Chan ◽  
...  

This paper aims to provide evidence-based recommendations for health professionals, to develop a comprehensive cervical cancer program for a clinic, a community, or a country. Ensuring access to healthcare is the responsibility of all societies, and the Asia Oceania Research Organisation in Genital Infections and Neoplasia (AOGIN) is committed to working collaboratively with governments and health professionals to facilitate prevention programs, to protect girls and women from cervical cancer, a disease that globally affects 500,000 and kills nearly 300,000 women annually, just over half of whom are in the Asia Oceania region. We share the vision that a comprehensive program of vaccination, screening, and treatment should be made accessible to all girls and women in the world. The primary purpose of these guidelines is to provide information on scientific evidence on the different modalities and approaches of cervical cancer prevention programs, for high resource and low resource settings. The secondary purpose is to provide an overview of the current situation of cervical cancer control and prevention in various Asian Oceania countries: their views of an ideal program, identified obstacles, and suggestions to overcome them are discussed.


2017 ◽  
Vol 115 (5) ◽  
pp. 615-618 ◽  
Author(s):  
Melissa S. Lopez ◽  
Ellen S. Baker ◽  
Mauricio Maza ◽  
Georgia Fontes-Cintra ◽  
Aldo Lopez ◽  
...  

2020 ◽  
Vol 5 (S1) ◽  
pp. 255-257
Author(s):  
Belinda Rina Marie Spagnoletti ◽  
Hanum Atikasari ◽  
Linda Rae Bennett ◽  
Henny M.A.R. Putri ◽  
Miranda Rachellina ◽  
...  

As Indonesia grapples with COVID-19, it remains vital that other crucial health interventions continue to be prioritised to minimise the overall health footprint of the epidemic. Cervical cancer is a preventable disease, yet it is the most lethal female cancer in Indonesia, responsible for more than 18,000 deaths each year. Thanks to the efforts of several key groups driving health reforms to step up cervical cancer control in recent years, Indonesia has a national screening program and, up until late 2019, a HPV vaccination pilot program was being rolled out across five provinces. An interdisciplinary four-year study exploring the experiences of and health system responses to cervical cancer in Indonesia was underway when the COVID-19 pandemic emerged. Alarmingly, the widespread restrictions on citizens’ mobility and the redistribution of resources to the COVID-19 response has resulted in key services for cervical cancer prevention and screening being paused indefinitely, without a clear path forward. Treat ent seeking, and the availability of support services for women with a cervical cancer diagnosis have also been interrupted. If unaddressed, these pauses will lead to an increase in women presenting with late stage cervical cancer, for which treatment is more invasive and costly, with a lower chance of survival. We are also concerned for the future generation of women in Indonesia, who, without access to affordable HPV vaccination, will face a heightened risk of developing cervical cancer compared with their peers from countries that have prioritised investing in this life saving vaccine.


Sign in / Sign up

Export Citation Format

Share Document